Rank | Gene Set | Z-score |
---|---|---|
1 | axonemal dynein complex assembly (GO:0070286) | 8.63186500 |
2 | cilium or flagellum-dependent cell motility (GO:0001539) | 8.00433029 |
3 | motile cilium assembly (GO:0044458) | 6.16282389 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.92174830 |
5 | L-phenylalanine catabolic process (GO:0006559) | 5.92174830 |
6 | L-phenylalanine metabolic process (GO:0006558) | 5.75508749 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75508749 |
8 | cilium movement (GO:0003341) | 5.49516390 |
9 | GDP-mannose metabolic process (GO:0019673) | 5.11693917 |
10 | thyroid hormone generation (GO:0006590) | 4.97730564 |
11 | aromatic amino acid family catabolic process (GO:0009074) | 4.95595747 |
12 | ethanol oxidation (GO:0006069) | 4.78188324 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63545396 |
14 | glyoxylate metabolic process (GO:0046487) | 4.48856913 |
15 | sulfur amino acid catabolic process (GO:0000098) | 4.47040129 |
16 | drug catabolic process (GO:0042737) | 4.38797234 |
17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37238051 |
18 | primary alcohol catabolic process (GO:0034310) | 4.37209248 |
19 | bile acid biosynthetic process (GO:0006699) | 4.35479974 |
20 | cysteine metabolic process (GO:0006534) | 4.32242648 |
21 | tryptophan metabolic process (GO:0006568) | 4.31904041 |
22 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.29168244 |
23 | epithelial cilium movement (GO:0003351) | 4.26874674 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.26750515 |
25 | thyroid hormone metabolic process (GO:0042403) | 4.21578785 |
26 | indolalkylamine catabolic process (GO:0046218) | 4.20916895 |
27 | tryptophan catabolic process (GO:0006569) | 4.20916895 |
28 | indole-containing compound catabolic process (GO:0042436) | 4.20916895 |
29 | kynurenine metabolic process (GO:0070189) | 4.18466603 |
30 | negative regulation of fibrinolysis (GO:0051918) | 4.07435511 |
31 | cellular glucuronidation (GO:0052695) | 4.05603688 |
32 | axoneme assembly (GO:0035082) | 4.05395724 |
33 | exogenous drug catabolic process (GO:0042738) | 3.99219675 |
34 | lung epithelium development (GO:0060428) | 3.97525131 |
35 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.94444465 |
36 | glutamate metabolic process (GO:0006536) | 3.88892879 |
37 | urea metabolic process (GO:0019627) | 3.88240843 |
38 | urea cycle (GO:0000050) | 3.88240843 |
39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.87769903 |
40 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.86426744 |
41 | uronic acid metabolic process (GO:0006063) | 3.85541783 |
42 | glucuronate metabolic process (GO:0019585) | 3.85541783 |
43 | tyrosine metabolic process (GO:0006570) | 3.84899841 |
44 | amino-acid betaine metabolic process (GO:0006577) | 3.83959982 |
45 | aromatic amino acid family metabolic process (GO:0009072) | 3.81262532 |
46 | left/right pattern formation (GO:0060972) | 3.77787350 |
47 | regulation of humoral immune response (GO:0002920) | 3.74843853 |
48 | lysine metabolic process (GO:0006553) | 3.74691849 |
49 | lysine catabolic process (GO:0006554) | 3.74691849 |
50 | bile acid metabolic process (GO:0008206) | 3.73900953 |
51 | serine family amino acid catabolic process (GO:0009071) | 3.70377815 |
52 | regulation of fibrinolysis (GO:0051917) | 3.68299356 |
53 | regulation of cholesterol esterification (GO:0010872) | 3.67313937 |
54 | vitamin transmembrane transport (GO:0035461) | 3.66357537 |
55 | reverse cholesterol transport (GO:0043691) | 3.65673588 |
56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.64552471 |
57 | nitrogen cycle metabolic process (GO:0071941) | 3.64438020 |
58 | response to nitrosative stress (GO:0051409) | 3.60831257 |
59 | flavonoid metabolic process (GO:0009812) | 3.60594129 |
60 | protein carboxylation (GO:0018214) | 3.60111832 |
61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60111832 |
62 | tolerance induction (GO:0002507) | 3.58334811 |
63 | negative regulation of lipase activity (GO:0060192) | 3.57142413 |
64 | cellular ketone body metabolic process (GO:0046950) | 3.54369198 |
65 | benzene-containing compound metabolic process (GO:0042537) | 3.51377910 |
66 | sensory perception of smell (GO:0007608) | 3.50677968 |
67 | regulation of apoptotic cell clearance (GO:2000425) | 3.50469624 |
68 | alpha-amino acid catabolic process (GO:1901606) | 3.50420503 |
69 | protein-lipid complex remodeling (GO:0034368) | 3.50053363 |
70 | macromolecular complex remodeling (GO:0034367) | 3.50053363 |
71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.50053363 |
72 | short-chain fatty acid metabolic process (GO:0046459) | 3.49713588 |
73 | regulation of protein activation cascade (GO:2000257) | 3.46703591 |
74 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.46208295 |
75 | xenobiotic catabolic process (GO:0042178) | 3.45984367 |
76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45579869 |
77 | mannose metabolic process (GO:0006013) | 3.40088212 |
78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38777239 |
79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38777239 |
80 | negative regulation of sterol transport (GO:0032372) | 3.37765638 |
81 | negative regulation of cholesterol transport (GO:0032375) | 3.37765638 |
82 | ethanol metabolic process (GO:0006067) | 3.37733790 |
83 | drug transmembrane transport (GO:0006855) | 3.34905456 |
84 | indolalkylamine metabolic process (GO:0006586) | 3.34884605 |
85 | cellular amino acid catabolic process (GO:0009063) | 3.34455202 |
86 | phospholipid efflux (GO:0033700) | 3.30273426 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 3.29834699 |
88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28857351 |
89 | triglyceride homeostasis (GO:0070328) | 3.28368228 |
90 | acylglycerol homeostasis (GO:0055090) | 3.28368228 |
91 | positive regulation of tolerance induction (GO:0002645) | 3.26843827 |
92 | renal absorption (GO:0070293) | 3.23977313 |
93 | regulation of triglyceride catabolic process (GO:0010896) | 3.22074885 |
94 | negative regulation of stress fiber assembly (GO:0051497) | 3.22000316 |
95 | aldehyde catabolic process (GO:0046185) | 3.21367189 |
96 | regulation of complement activation (GO:0030449) | 3.21354092 |
97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.20254652 |
98 | complement activation, alternative pathway (GO:0006957) | 3.18583081 |
99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17817647 |
100 | imidazole-containing compound metabolic process (GO:0052803) | 3.17143875 |
101 | coenzyme catabolic process (GO:0009109) | 3.16661622 |
102 | regulation of cholesterol homeostasis (GO:2000188) | 3.16660426 |
103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.16012919 |
104 | cholesterol efflux (GO:0033344) | 3.15930137 |
105 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.15405507 |
106 | negative regulation of B cell mediated immunity (GO:0002713) | 3.12045740 |
107 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.12045740 |
108 | drug metabolic process (GO:0017144) | 3.11140757 |
109 | negative regulation of humoral immune response (GO:0002921) | 3.07299758 |
110 | regulation of cholesterol metabolic process (GO:0090181) | 3.04477410 |
111 | L-ascorbic acid metabolic process (GO:0019852) | 3.03317826 |
112 | ketone body metabolic process (GO:1902224) | 3.03169752 |
113 | response to pheromone (GO:0019236) | 3.00030822 |
114 | bile acid and bile salt transport (GO:0015721) | 2.99686012 |
115 | carnitine metabolic process (GO:0009437) | 2.99602678 |
116 | carboxylic acid catabolic process (GO:0046395) | 2.97782398 |
117 | organic acid catabolic process (GO:0016054) | 2.97782398 |
118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95112092 |
119 | negative regulation of protein activation cascade (GO:2000258) | 2.94813183 |
120 | homocysteine metabolic process (GO:0050667) | 2.92330865 |
121 | gamma-aminobutyric acid transport (GO:0015812) | 2.91413133 |
122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.90613400 |
123 | arginine metabolic process (GO:0006525) | 2.89503872 |
124 | monocarboxylic acid catabolic process (GO:0072329) | 2.89339692 |
125 | drug transport (GO:0015893) | 2.87613139 |
126 | regulation of tolerance induction (GO:0002643) | 2.86925573 |
127 | fatty acid oxidation (GO:0019395) | 2.86816843 |
128 | plasma lipoprotein particle clearance (GO:0034381) | 2.85405252 |
129 | positive regulation of extracellular matrix organization (GO:1903055) | 2.85045156 |
130 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.83122592 |
131 | cellular biogenic amine catabolic process (GO:0042402) | 2.83089177 |
132 | amine catabolic process (GO:0009310) | 2.83089177 |
133 | aspartate family amino acid catabolic process (GO:0009068) | 2.82984114 |
134 | positive regulation of protein kinase C signaling (GO:0090037) | 2.82724725 |
135 | low-density lipoprotein particle remodeling (GO:0034374) | 2.81811677 |
136 | lipid oxidation (GO:0034440) | 2.81678065 |
137 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.80454034 |
138 | regulation of interleukin-13 production (GO:0032656) | 2.78879268 |
139 | positive thymic T cell selection (GO:0045059) | 2.78719810 |
140 | regulation of plasminogen activation (GO:0010755) | 2.77028847 |
141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74941897 |
142 | phenylpropanoid metabolic process (GO:0009698) | 2.74274202 |
143 | phosphate ion transmembrane transport (GO:0035435) | 2.72615541 |
144 | peptidyl-glutamic acid modification (GO:0018200) | 2.68836808 |
145 | fibrinolysis (GO:0042730) | 2.66994624 |
146 | proline metabolic process (GO:0006560) | 2.66924814 |
147 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.66577302 |
148 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.66027113 |
149 | negative regulation of cell killing (GO:0031342) | 2.66027113 |
150 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.65346165 |
151 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.64785000 |
152 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.63160439 |
153 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63103791 |
154 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.61222656 |
155 | detection of bacterium (GO:0016045) | 2.58574373 |
156 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57352590 |
157 | thymic T cell selection (GO:0045061) | 2.57214562 |
158 | adenosine receptor signaling pathway (GO:0001973) | 2.56731949 |
159 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56084950 |
160 | response to phenylpropanoid (GO:0080184) | 2.54475061 |
161 | muscle organ morphogenesis (GO:0048644) | 2.53011044 |
162 | protein activation cascade (GO:0072376) | 2.51983141 |
163 | positive regulation of steroid metabolic process (GO:0045940) | 2.51255954 |
164 | primary alcohol metabolic process (GO:0034308) | 2.48921841 |
165 | glutathione biosynthetic process (GO:0006750) | 2.46897707 |
166 | regulation of skeletal muscle contraction (GO:0014819) | 2.46494422 |
167 | multicellular organismal water homeostasis (GO:0050891) | 2.44547721 |
168 | plasma lipoprotein particle assembly (GO:0034377) | 2.44462661 |
169 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.43697851 |
170 | cellular response to ATP (GO:0071318) | 2.42526459 |
171 | sperm capacitation (GO:0048240) | 2.42453263 |
172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41185004 |
173 | progesterone metabolic process (GO:0042448) | 2.39944759 |
174 | acute-phase response (GO:0006953) | 2.39431340 |
175 | regulation of interleukin-5 production (GO:0032674) | 2.38657461 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.87594433 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24772057 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.32220680 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05726859 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.30072942 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.22817566 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.19565964 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.15325213 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13345793 |
10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.82709824 |
11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.78365966 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.74177326 |
13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.59812178 |
14 | P68_20966046_ChIP-Seq_HELA_Human | 2.41638929 |
15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.41303779 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19593003 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.14202807 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03969666 |
19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03787319 |
20 | MAF_26560356_Chip-Seq_TH2_Human | 2.02209981 |
21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00921642 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.99762978 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.98487312 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.93075877 |
25 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.92165601 |
26 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.84077953 |
27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.83955176 |
28 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.83753780 |
29 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.82426924 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81710898 |
31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78408602 |
32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76282745 |
33 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.76046782 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75466987 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74286755 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72792210 |
37 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70733665 |
38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70486271 |
39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70486271 |
40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69725293 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69426965 |
42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68831174 |
43 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.67195299 |
44 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.64113115 |
45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56629956 |
46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56445841 |
47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56118137 |
48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52466724 |
49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50233376 |
50 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.49050934 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45586065 |
52 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44469428 |
53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43647053 |
54 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.43233831 |
55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42307049 |
56 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42210323 |
57 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40605808 |
58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39914308 |
59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39841313 |
60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39548865 |
61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38983127 |
62 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.38361458 |
63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37388703 |
64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34948437 |
65 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34285067 |
66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32893105 |
67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29356141 |
68 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29143239 |
69 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.29051405 |
70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28941316 |
71 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.28789407 |
72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.27318641 |
73 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.26917974 |
74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26087081 |
75 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26004241 |
76 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25938656 |
77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25866570 |
78 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24619280 |
79 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.24061283 |
80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23989159 |
81 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23280405 |
82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22849981 |
83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20715112 |
84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20022697 |
85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18383988 |
86 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18166844 |
87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15733837 |
88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14858134 |
89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14838007 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14415974 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14044303 |
92 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12880164 |
93 | P300_27268052_Chip-Seq_Bcells_Human | 1.12431913 |
94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12167320 |
95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11841611 |
96 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11763439 |
97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10782641 |
98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09519570 |
99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09001224 |
100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08845054 |
101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08399977 |
102 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07801187 |
103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07443565 |
104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07269727 |
105 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07181718 |
106 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06430779 |
107 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05145535 |
108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04466269 |
109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04015475 |
110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03904204 |
111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03104278 |
112 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02840433 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02208232 |
114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01819081 |
115 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01570215 |
116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01189358 |
117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00281537 |
118 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00040178 |
119 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99784580 |
120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96715672 |
121 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95780845 |
122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94652559 |
123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93720784 |
124 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93409612 |
125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92299024 |
126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91426770 |
127 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87817809 |
128 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.87214229 |
129 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86783308 |
130 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85324210 |
131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83513160 |
132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83512572 |
133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82625854 |
134 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82235871 |
135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81610166 |
136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81395106 |
137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79041091 |
138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79029831 |
139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78010761 |
140 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77959152 |
141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76742099 |
142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76433294 |
143 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.75432847 |
144 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75133449 |
145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.74956099 |
146 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73975462 |
147 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.72953243 |
148 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72789494 |
149 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72372737 |
150 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71509537 |
151 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.70110462 |
152 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.70083906 |
153 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66821152 |
154 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.66331925 |
155 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.66066218 |
156 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.65588925 |
157 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.65009934 |
158 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64963055 |
159 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64519292 |
160 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64322868 |
161 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63582760 |
162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.63440956 |
163 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.63389442 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.67558370 |
2 | MP0008875_abnormal_xenobiotic_pharmacok | 5.75845074 |
3 | MP0005360_urolithiasis | 5.71536183 |
4 | MP0005365_abnormal_bile_salt | 4.93895742 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.40798523 |
6 | MP0001984_abnormal_olfaction | 3.74124898 |
7 | MP0002132_abnormal_respiratory_system | 3.57396976 |
8 | MP0005377_hearing/vestibular/ear_phenot | 3.17080679 |
9 | MP0003878_abnormal_ear_physiology | 3.17080679 |
10 | MP0009840_abnormal_foam_cell | 3.14958592 |
11 | MP0010329_abnormal_lipoprotein_level | 2.96985254 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.93421811 |
13 | MP0003252_abnormal_bile_duct | 2.91483315 |
14 | MP0001986_abnormal_taste_sensitivity | 2.86126931 |
15 | MP0003195_calcinosis | 2.65063846 |
16 | MP0005083_abnormal_biliary_tract | 2.52881184 |
17 | MP0003136_yellow_coat_color | 2.47860391 |
18 | MP0005332_abnormal_amino_acid | 2.41589851 |
19 | MP0002277_abnormal_respiratory_mucosa | 2.31424572 |
20 | MP0004381_abnormal_hair_follicle | 2.20794479 |
21 | MP0005409_darkened_coat_color | 2.19375680 |
22 | MP0001661_extended_life_span | 2.03174641 |
23 | MP0004043_abnormal_pH_regulation | 1.99516520 |
24 | MP0003763_abnormal_thymus_physiology | 1.96577322 |
25 | MP0004859_abnormal_synaptic_plasticity | 1.95310822 |
26 | MP0003436_decreased_susceptibility_to | 1.85710803 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.85334654 |
28 | MP0004019_abnormal_vitamin_homeostasis | 1.84786685 |
29 | MP0001666_abnormal_nutrient_absorption | 1.82679135 |
30 | MP0003172_abnormal_lysosome_physiology | 1.78503266 |
31 | MP0003303_peritoneal_inflammation | 1.74913191 |
32 | MP0002118_abnormal_lipid_homeostasis | 1.73287213 |
33 | MP0003011_delayed_dark_adaptation | 1.72528611 |
34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72359195 |
35 | MP0005387_immune_system_phenotype | 1.65140243 |
36 | MP0001790_abnormal_immune_system | 1.65140243 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.65073637 |
38 | MP0003329_amyloid_beta_deposits | 1.62972258 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.56086476 |
40 | MP0000003_abnormal_adipose_tissue | 1.55287752 |
41 | MP0000685_abnormal_immune_system | 1.53485418 |
42 | MP0000013_abnormal_adipose_tissue | 1.53230806 |
43 | MP0003868_abnormal_feces_composition | 1.47333300 |
44 | MP0010155_abnormal_intestine_physiology | 1.47106867 |
45 | MP0003453_abnormal_keratinocyte_physiol | 1.46287469 |
46 | MP0003635_abnormal_synaptic_transmissio | 1.44530535 |
47 | MP0000609_abnormal_liver_physiology | 1.42495771 |
48 | MP0002653_abnormal_ependyma_morphology | 1.41094960 |
49 | MP0009745_abnormal_behavioral_response | 1.41060659 |
50 | MP0005394_taste/olfaction_phenotype | 1.40357290 |
51 | MP0005499_abnormal_olfactory_system | 1.40357290 |
52 | MP0005319_abnormal_enzyme/_coenzyme | 1.38867650 |
53 | MP0000681_abnormal_thyroid_gland | 1.37633026 |
54 | MP0002933_joint_inflammation | 1.36822143 |
55 | MP0005666_abnormal_adipose_tissue | 1.36466349 |
56 | MP0009643_abnormal_urine_homeostasis | 1.35045446 |
57 | MP0005375_adipose_tissue_phenotype | 1.35043781 |
58 | MP0001800_abnormal_humoral_immune | 1.29973175 |
59 | MP0003879_abnormal_hair_cell | 1.27552761 |
60 | MP0005025_abnormal_response_to | 1.26015515 |
61 | MP0009046_muscle_twitch | 1.24219205 |
62 | MP0001501_abnormal_sleep_pattern | 1.22622439 |
63 | MP0002909_abnormal_adrenal_gland | 1.20255753 |
64 | MP0005671_abnormal_response_to | 1.20095769 |
65 | MP0005058_abnormal_lysosome_morphology | 1.19720356 |
66 | MP0004130_abnormal_muscle_cell | 1.19276790 |
67 | MP0002272_abnormal_nervous_system | 1.17372449 |
68 | MP0003690_abnormal_glial_cell | 1.14438280 |
69 | MP0002876_abnormal_thyroid_physiology | 1.14410368 |
70 | MP0010234_abnormal_vibrissa_follicle | 1.13824148 |
71 | MP0005076_abnormal_cell_differentiation | 1.13302301 |
72 | MP0000566_synostosis | 1.12881584 |
73 | MP0005623_abnormal_meninges_morphology | 1.11852923 |
74 | MP0005464_abnormal_platelet_physiology | 1.11724636 |
75 | MP0000604_amyloidosis | 1.11670651 |
76 | MP0002063_abnormal_learning/memory/cond | 1.11627326 |
77 | MP0010368_abnormal_lymphatic_system | 1.11359630 |
78 | MP0002064_seizures | 1.11074689 |
79 | MP0005000_abnormal_immune_tolerance | 1.11066964 |
80 | MP0000678_abnormal_parathyroid_gland | 1.10505654 |
81 | MP0005636_abnormal_mineral_homeostasis | 1.09698689 |
82 | MP0002136_abnormal_kidney_physiology | 1.06759031 |
83 | MP0004947_skin_inflammation | 1.06490923 |
84 | MP0002723_abnormal_immune_serum | 1.05999403 |
85 | MP0002822_catalepsy | 1.05608493 |
86 | MP0005423_abnormal_somatic_nervous | 1.02218670 |
87 | MP0001756_abnormal_urination | 1.02103182 |
88 | MP0003091_abnormal_cell_migration | 1.01520324 |
89 | MP0002249_abnormal_larynx_morphology | 1.01277764 |
90 | MP0008872_abnormal_physiological_respon | 1.01046965 |
91 | MP0002405_respiratory_system_inflammati | 1.00992879 |
92 | MP0008469_abnormal_protein_level | 0.98324296 |
93 | MP0008874_decreased_physiological_sensi | 0.98205374 |
94 | MP0008789_abnormal_olfactory_epithelium | 0.98158479 |
95 | MP0001879_abnormal_lymphatic_vessel | 0.96923780 |
96 | MP0003075_altered_response_to | 0.96508116 |
97 | MP0002452_abnormal_antigen_presenting | 0.95947535 |
98 | MP0000751_myopathy | 0.94476198 |
99 | MP0002572_abnormal_emotion/affect_behav | 0.94147097 |
100 | MP0005670_abnormal_white_adipose | 0.93466922 |
101 | MP0005535_abnormal_body_temperature | 0.92899391 |
102 | MP0003186_abnormal_redox_activity | 0.92831974 |
103 | MP0009764_decreased_sensitivity_to | 0.91667899 |
104 | MP0002420_abnormal_adaptive_immunity | 0.91367566 |
105 | MP0009785_altered_susceptibility_to | 0.90726881 |
106 | MP0008569_lethality_at_weaning | 0.90601607 |
107 | MP0001819_abnormal_immune_cell | 0.90551821 |
108 | MP0005330_cardiomyopathy | 0.90217698 |
109 | MP0001765_abnormal_ion_homeostasis | 0.90209998 |
110 | MP0005084_abnormal_gallbladder_morpholo | 0.89111511 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.88823812 |
112 | MP0004885_abnormal_endolymph | 0.86941020 |
113 | MP0005174_abnormal_tail_pigmentation | 0.85783424 |
114 | MP0005645_abnormal_hypothalamus_physiol | 0.84229903 |
115 | MP0009765_abnormal_xenobiotic_induced | 0.84020703 |
116 | MP0003866_abnormal_defecation | 0.82231759 |
117 | MP0003638_abnormal_response/metabolism_ | 0.82203931 |
118 | MP0002398_abnormal_bone_marrow | 0.81426217 |
119 | MP0001764_abnormal_homeostasis | 0.81134709 |
120 | MP0000249_abnormal_blood_vessel | 0.80991739 |
121 | MP0000858_altered_metastatic_potential | 0.80835109 |
122 | MP0002419_abnormal_innate_immunity | 0.79132548 |
123 | MP0002557_abnormal_social/conspecific_i | 0.78977793 |
124 | MP0002078_abnormal_glucose_homeostasis | 0.78963621 |
125 | MP0001958_emphysema | 0.78199625 |
126 | MP0001845_abnormal_inflammatory_respons | 0.77511094 |
127 | MP0009697_abnormal_copulation | 0.77208646 |
128 | MP0001849_ear_inflammation | 0.76894505 |
129 | MP0000716_abnormal_immune_system | 0.76827501 |
130 | MP0001873_stomach_inflammation | 0.76538028 |
131 | MP0002102_abnormal_ear_morphology | 0.76411825 |
132 | MP0005220_abnormal_exocrine_pancreas | 0.76222564 |
133 | MP0001968_abnormal_touch/_nociception | 0.74834616 |
134 | MP0005171_absent_coat_pigmentation | 0.73926069 |
135 | MP0001835_abnormal_antigen_presentation | 0.73905695 |
136 | MP0002734_abnormal_mechanical_nocicepti | 0.73535212 |
137 | MP0006036_abnormal_mitochondrial_physio | 0.72881840 |
138 | MP0001440_abnormal_grooming_behavior | 0.72016070 |
139 | MP0002067_abnormal_sensory_capabilities | 0.71893801 |
140 | MP0004270_analgesia | 0.70829601 |
141 | MP0009642_abnormal_blood_homeostasis | 0.70620527 |
142 | MP0003633_abnormal_nervous_system | 0.70234376 |
143 | MP0003953_abnormal_hormone_level | 0.70017930 |
144 | MP0005647_abnormal_sex_gland | 0.68585564 |
145 | MP0003705_abnormal_hypodermis_morpholog | 0.66864089 |
146 | MP0005167_abnormal_blood-brain_barrier | 0.65882343 |
147 | MP0002184_abnormal_innervation | 0.65651242 |
148 | MP0002736_abnormal_nociception_after | 0.64325170 |
149 | MP0004782_abnormal_surfactant_physiolog | 0.63958903 |
150 | MP0002168_other_aberrant_phenotype | 0.63257468 |
151 | MP0001177_atelectasis | 0.62921943 |
152 | MP0002971_abnormal_brown_adipose | 0.62840287 |
153 | MP0003656_abnormal_erythrocyte_physiolo | 0.62440577 |
154 | MP0002928_abnormal_bile_duct | 0.62392307 |
155 | MP0001502_abnormal_circadian_rhythm | 0.60617715 |
156 | MP0005187_abnormal_penis_morphology | 0.59586587 |
157 | MP0000598_abnormal_liver_morphology | 0.59214341 |
158 | MP0002069_abnormal_eating/drinking_beha | 0.59051473 |
159 | MP0001486_abnormal_startle_reflex | 0.58128591 |
160 | MP0005451_abnormal_body_composition | 0.57731330 |
161 | MP0005448_abnormal_energy_balance | 0.57491179 |
162 | MP0000639_abnormal_adrenal_gland | 0.57209401 |
163 | MP0005376_homeostasis/metabolism_phenot | 0.56753700 |
164 | MP0005595_abnormal_vascular_smooth | 0.55527382 |
165 | MP0002254_reproductive_system_inflammat | 0.55037414 |
166 | MP0004142_abnormal_muscle_tone | 0.53701451 |
167 | MP0002735_abnormal_chemical_nociception | 0.53376533 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.44651552 |
2 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.93637998 |
3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.93637998 |
4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.56174411 |
5 | Abnormal ciliary motility (HP:0012262) | 6.42235124 |
6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.42078475 |
7 | Absent/shortened dynein arms (HP:0200106) | 6.42078475 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.16980660 |
9 | Rhinitis (HP:0012384) | 5.93395487 |
10 | Nasal polyposis (HP:0100582) | 5.72186570 |
11 | Deep venous thrombosis (HP:0002625) | 5.47487006 |
12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.06515900 |
13 | Bronchiectasis (HP:0002110) | 5.04831532 |
14 | Abnormality of the nasal mucosa (HP:0000433) | 5.03056819 |
15 | Intrahepatic cholestasis (HP:0001406) | 4.61950210 |
16 | Hyperactive renin-angiotensin system (HP:0000841) | 4.54468221 |
17 | Hemorrhage of the eye (HP:0011885) | 4.48342250 |
18 | Xanthomatosis (HP:0000991) | 4.45223172 |
19 | Hyperlipoproteinemia (HP:0010980) | 4.38945309 |
20 | Hypobetalipoproteinemia (HP:0003563) | 4.35441788 |
21 | Prolonged partial thromboplastin time (HP:0003645) | 4.34296501 |
22 | Recurrent sinusitis (HP:0011108) | 4.19619267 |
23 | Delayed CNS myelination (HP:0002188) | 4.08095811 |
24 | Ketosis (HP:0001946) | 3.81490195 |
25 | Testicular atrophy (HP:0000029) | 3.70247485 |
26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65504119 |
27 | Hypokalemic alkalosis (HP:0001949) | 3.64065729 |
28 | Recurrent otitis media (HP:0000403) | 3.45459100 |
29 | Bronchitis (HP:0012387) | 3.44666395 |
30 | Chronic bronchitis (HP:0004469) | 3.44155612 |
31 | Gout (HP:0001997) | 3.43853938 |
32 | Ketoacidosis (HP:0001993) | 3.40900842 |
33 | Hyperammonemia (HP:0001987) | 3.37325594 |
34 | Hyperglycinuria (HP:0003108) | 3.37251794 |
35 | Goiter (HP:0000853) | 3.32123419 |
36 | Alkalosis (HP:0001948) | 3.31202630 |
37 | Chronic sinusitis (HP:0011109) | 3.24719961 |
38 | Hyperglycinemia (HP:0002154) | 3.21830466 |
39 | Hyperaldosteronism (HP:0000859) | 3.20133133 |
40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.17674219 |
41 | Hypolipoproteinemia (HP:0010981) | 3.17364749 |
42 | Joint hemorrhage (HP:0005261) | 3.09363237 |
43 | Thin bony cortex (HP:0002753) | 3.08765168 |
44 | Male infertility (HP:0003251) | 3.01321277 |
45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99185655 |
46 | Abnormality of glycine metabolism (HP:0010895) | 2.99185655 |
47 | Complement deficiency (HP:0004431) | 2.97665354 |
48 | Atelectasis (HP:0100750) | 2.94430925 |
49 | Infertility (HP:0000789) | 2.90935386 |
50 | Metabolic acidosis (HP:0001942) | 2.90384292 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.90266898 |
52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.85715180 |
53 | Hypoalphalipoproteinemia (HP:0003233) | 2.83319312 |
54 | Hypoglycemic coma (HP:0001325) | 2.82679979 |
55 | Renal salt wasting (HP:0000127) | 2.81507502 |
56 | Hyperbilirubinemia (HP:0002904) | 2.78945477 |
57 | Chronic otitis media (HP:0000389) | 2.77401280 |
58 | Annular pancreas (HP:0001734) | 2.73284560 |
59 | Epidermoid cyst (HP:0200040) | 2.73269853 |
60 | Decreased circulating renin level (HP:0003351) | 2.72213550 |
61 | Fat malabsorption (HP:0002630) | 2.69151279 |
62 | Recurrent bronchitis (HP:0002837) | 2.67840546 |
63 | Vascular calcification (HP:0004934) | 2.65825234 |
64 | Status epilepticus (HP:0002133) | 2.65192816 |
65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63038592 |
66 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61002546 |
67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.56198725 |
68 | Mesangial abnormality (HP:0001966) | 2.55455948 |
69 | Abnormality of purine metabolism (HP:0004352) | 2.54991863 |
70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52526251 |
71 | Vaginal fistula (HP:0004320) | 2.51189166 |
72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50024160 |
73 | Glomerulonephritis (HP:0000099) | 2.48704004 |
74 | Aplasia of the musculature (HP:0100854) | 2.46358100 |
75 | Abnormality of chloride homeostasis (HP:0011422) | 2.43806791 |
76 | Hypercholesterolemia (HP:0003124) | 2.41012185 |
77 | Neonatal onset (HP:0003623) | 2.40559468 |
78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37984182 |
79 | Thyroid-stimulating hormone excess (HP:0002925) | 2.35210299 |
80 | Abnormality of renin-angiotensin system (HP:0000847) | 2.34742905 |
81 | Late onset (HP:0003584) | 2.34141272 |
82 | Cardiovascular calcification (HP:0011915) | 2.29581143 |
83 | Systemic lupus erythematosus (HP:0002725) | 2.28704647 |
84 | Obstructive sleep apnea (HP:0002870) | 2.28136311 |
85 | Visual hallucinations (HP:0002367) | 2.24918117 |
86 | Pili torti (HP:0003777) | 2.24770008 |
87 | Popliteal pterygium (HP:0009756) | 2.22923998 |
88 | Sensorimotor neuropathy (HP:0007141) | 2.19728597 |
89 | Hyperkalemia (HP:0002153) | 2.19643809 |
90 | Action tremor (HP:0002345) | 2.19567856 |
91 | Abnormality of methionine metabolism (HP:0010901) | 2.19341854 |
92 | Spontaneous abortion (HP:0005268) | 2.18704270 |
93 | Purpura (HP:0000979) | 2.18244759 |
94 | Irritability (HP:0000737) | 2.16321972 |
95 | Esophageal varix (HP:0002040) | 2.16072618 |
96 | Ulnar bowing (HP:0003031) | 2.15656827 |
97 | Confusion (HP:0001289) | 2.15000807 |
98 | Abnormality of the lower motor neuron (HP:0002366) | 2.14119484 |
99 | Gastrointestinal stroma tumor (HP:0100723) | 2.08724524 |
100 | Emphysema (HP:0002097) | 2.08702603 |
101 | Amyloidosis (HP:0011034) | 2.05043336 |
102 | Spastic diplegia (HP:0001264) | 2.05039945 |
103 | Hepatocellular carcinoma (HP:0001402) | 2.04902524 |
104 | Focal dystonia (HP:0004373) | 2.04053854 |
105 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03968820 |
106 | Nephritis (HP:0000123) | 2.03891061 |
107 | Occipital encephalocele (HP:0002085) | 2.02821544 |
108 | Abnormality of complement system (HP:0005339) | 2.01765033 |
109 | Craniofacial dystonia (HP:0012179) | 2.00928283 |
110 | Hypoglycemic seizures (HP:0002173) | 2.00156526 |
111 | Decreased central vision (HP:0007663) | 1.99510238 |
112 | Hypochromic microcytic anemia (HP:0004840) | 1.99150974 |
113 | Dyschromatopsia (HP:0007641) | 1.98705820 |
114 | Torticollis (HP:0000473) | 1.98047639 |
115 | Abnormality of sodium homeostasis (HP:0010931) | 1.97431282 |
116 | Atrioventricular block (HP:0001678) | 1.97096385 |
117 | Hyperuricemia (HP:0002149) | 1.97060000 |
118 | Increased purine levels (HP:0004368) | 1.97060000 |
119 | Focal motor seizures (HP:0011153) | 1.96874150 |
120 | Rib fusion (HP:0000902) | 1.96803082 |
121 | Myokymia (HP:0002411) | 1.96327295 |
122 | Lethargy (HP:0001254) | 1.94680059 |
123 | Poikilocytosis (HP:0004447) | 1.94399655 |
124 | Fetal akinesia sequence (HP:0001989) | 1.93406236 |
125 | Steatorrhea (HP:0002570) | 1.93218431 |
126 | Epistaxis (HP:0000421) | 1.92924078 |
127 | Intestinal fistula (HP:0100819) | 1.91817517 |
128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90533171 |
129 | Mucopolysacchariduria (HP:0008155) | 1.90533171 |
130 | Abnormal hair laboratory examination (HP:0003328) | 1.89735417 |
131 | Cholelithiasis (HP:0001081) | 1.89715282 |
132 | Tetany (HP:0001281) | 1.89666329 |
133 | Abnormality of serum amino acid levels (HP:0003112) | 1.89657565 |
134 | Abnormal gallbladder morphology (HP:0012437) | 1.89384772 |
135 | Renal tubular acidosis (HP:0001947) | 1.88000729 |
136 | Menorrhagia (HP:0000132) | 1.87820391 |
137 | Turricephaly (HP:0000262) | 1.87496610 |
138 | Vomiting (HP:0002013) | 1.85674204 |
139 | Death in childhood (HP:0003819) | 1.85105824 |
140 | Joint stiffness (HP:0001387) | 1.84798897 |
141 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.84120253 |
142 | Malnutrition (HP:0004395) | 1.84114996 |
143 | Nephrolithiasis (HP:0000787) | 1.84059469 |
144 | Tetraplegia (HP:0002445) | 1.84022314 |
145 | Polycythemia (HP:0001901) | 1.83721063 |
146 | Metabolic alkalosis (HP:0200114) | 1.83459124 |
147 | Abnormal gallbladder physiology (HP:0012438) | 1.82850135 |
148 | Cholecystitis (HP:0001082) | 1.82850135 |
149 | Rectal fistula (HP:0100590) | 1.82666326 |
150 | Rectovaginal fistula (HP:0000143) | 1.82666326 |
151 | Colitis (HP:0002583) | 1.82449520 |
152 | Hypertriglyceridemia (HP:0002155) | 1.80991286 |
153 | Hyponatremia (HP:0002902) | 1.80842185 |
154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80274968 |
155 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80274968 |
156 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80274968 |
157 | Brushfield spots (HP:0001088) | 1.79637522 |
158 | Adrenal overactivity (HP:0002717) | 1.78323239 |
159 | Eczematoid dermatitis (HP:0000976) | 1.77929158 |
160 | Anteriorly placed anus (HP:0001545) | 1.72436930 |
161 | Stridor (HP:0010307) | 1.70327349 |
162 | Gastrointestinal infarctions (HP:0005244) | 1.69150540 |
163 | Increased serum ferritin (HP:0003281) | 1.67621680 |
164 | Hypophosphatemic rickets (HP:0004912) | 1.66497121 |
165 | Cervical subluxation (HP:0003308) | 1.66474584 |
166 | Poikiloderma (HP:0001029) | 1.62043824 |
167 | Attenuation of retinal blood vessels (HP:0007843) | 1.58119248 |
168 | Myopathic facies (HP:0002058) | 1.56707840 |
169 | Rickets (HP:0002748) | 1.56121657 |
170 | Increased IgE level (HP:0003212) | 1.55860177 |
171 | Increased muscle lipid content (HP:0009058) | 1.53116609 |
172 | Abnormality of the radial head (HP:0003995) | 1.52108170 |
173 | Polygenic inheritance (HP:0010982) | 1.51597972 |
174 | Dislocated radial head (HP:0003083) | 1.49448771 |
175 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.46820648 |
176 | Widely patent fontanelles and sutures (HP:0004492) | 1.44846007 |
177 | Abnormal albumin level (HP:0012116) | 1.44796948 |
178 | Hypoalbuminemia (HP:0003073) | 1.44796948 |
179 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.41842916 |
180 | Myositis (HP:0100614) | 1.41515188 |
181 | Meningitis (HP:0001287) | 1.41368262 |
182 | Gastrointestinal inflammation (HP:0004386) | 1.39903150 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 3.61160623 |
2 | BCKDK | 3.53862410 |
3 | DAPK2 | 3.06036329 |
4 | CAMKK2 | 2.96252395 |
5 | SMG1 | 2.78597371 |
6 | RIPK1 | 2.57330340 |
7 | MAP2K4 | 2.53013876 |
8 | MAP4K1 | 2.51243642 |
9 | RIPK4 | 2.47195508 |
10 | ERN1 | 2.36444387 |
11 | NTRK3 | 2.24801677 |
12 | SIK1 | 2.03846710 |
13 | CAMKK1 | 2.00508793 |
14 | TBK1 | 1.94817689 |
15 | LMTK2 | 1.78889972 |
16 | EPHA2 | 1.78357672 |
17 | GRK6 | 1.77896447 |
18 | PRPF4B | 1.76573244 |
19 | BLK | 1.73592998 |
20 | MAP3K4 | 1.73146402 |
21 | TAOK1 | 1.72767175 |
22 | ERBB3 | 1.70453393 |
23 | STK38 | 1.67128777 |
24 | PINK1 | 1.64360897 |
25 | FLT3 | 1.62962222 |
26 | NME1 | 1.59478209 |
27 | CSK | 1.58288436 |
28 | MAP3K9 | 1.56673975 |
29 | TNIK | 1.55439827 |
30 | TRIB3 | 1.55211254 |
31 | EPHA4 | 1.49191884 |
32 | MAP3K2 | 1.44105392 |
33 | TYK2 | 1.43865533 |
34 | MINK1 | 1.43481807 |
35 | ZAP70 | 1.40005014 |
36 | MAP2K7 | 1.38813988 |
37 | STK16 | 1.36833608 |
38 | MAP2K3 | 1.34276524 |
39 | DAPK1 | 1.31726355 |
40 | KDR | 1.30872257 |
41 | MAPKAPK3 | 1.27628528 |
42 | STK24 | 1.27526852 |
43 | INSRR | 1.27322001 |
44 | MAP3K13 | 1.26032237 |
45 | PIM2 | 1.25299111 |
46 | CAMK2G | 1.21972327 |
47 | MST4 | 1.20463517 |
48 | ICK | 1.19893307 |
49 | LRRK2 | 1.17755446 |
50 | PASK | 1.17726493 |
51 | MAP3K6 | 1.16190682 |
52 | FRK | 1.15505283 |
53 | PRKCG | 1.14584509 |
54 | CAMK2B | 1.14534599 |
55 | CAMK1 | 1.14353866 |
56 | CDK19 | 1.13942075 |
57 | TNK2 | 1.11957606 |
58 | PAK3 | 1.11396294 |
59 | BTK | 1.10935529 |
60 | MAP3K3 | 1.09856324 |
61 | FGFR4 | 1.09471069 |
62 | CAMK4 | 1.09405599 |
63 | FER | 1.08373830 |
64 | MAP3K10 | 1.07281566 |
65 | PTK2 | 1.05077344 |
66 | CAMK1G | 1.04623334 |
67 | CAMK1D | 1.03176060 |
68 | PRKD2 | 0.98869715 |
69 | CAMK2D | 0.98488477 |
70 | TLK1 | 0.97757797 |
71 | MAP3K7 | 0.96610984 |
72 | NTRK2 | 0.96174456 |
73 | MAP2K6 | 0.95949622 |
74 | TESK1 | 0.95018004 |
75 | PTK6 | 0.93518422 |
76 | PIK3CG | 0.92621280 |
77 | PRKG2 | 0.91251240 |
78 | KSR2 | 0.89319122 |
79 | PAK6 | 0.87722464 |
80 | CDK4 | 0.87658809 |
81 | TIE1 | 0.87238650 |
82 | IKBKE | 0.87090784 |
83 | OXSR1 | 0.86523126 |
84 | TXK | 0.86467494 |
85 | CDC42BPA | 0.85870374 |
86 | EEF2K | 0.84824512 |
87 | WNK4 | 0.82482089 |
88 | TAOK3 | 0.82260586 |
89 | PHKG1 | 0.79963860 |
90 | PHKG2 | 0.79963860 |
91 | SGK494 | 0.79742001 |
92 | SGK223 | 0.79742001 |
93 | DYRK1B | 0.79697044 |
94 | SGK3 | 0.78831993 |
95 | MAPK7 | 0.78748637 |
96 | TEC | 0.78028873 |
97 | MAP3K1 | 0.76624747 |
98 | RET | 0.73155038 |
99 | NTRK1 | 0.72239742 |
100 | MAP2K2 | 0.72045769 |
101 | PRKCQ | 0.72011632 |
102 | PDPK1 | 0.70975449 |
103 | HIPK2 | 0.70255754 |
104 | JAK1 | 0.68345521 |
105 | MAP3K14 | 0.67973319 |
106 | SYK | 0.66600736 |
107 | SIK2 | 0.64802045 |
108 | SGK2 | 0.64767223 |
109 | BMPR2 | 0.64535688 |
110 | IRAK4 | 0.63900148 |
111 | CAMK2A | 0.63787416 |
112 | HCK | 0.63622001 |
113 | PKN2 | 0.61580133 |
114 | PRKCZ | 0.61207028 |
115 | CDK5 | 0.61191620 |
116 | ARAF | 0.60814656 |
117 | JAK3 | 0.60484396 |
118 | FES | 0.60425981 |
119 | MST1R | 0.60264278 |
120 | IKBKB | 0.60261941 |
121 | MARK2 | 0.59791971 |
122 | RPS6KC1 | 0.59065585 |
123 | RPS6KL1 | 0.59065585 |
124 | UHMK1 | 0.59045341 |
125 | WNK3 | 0.58338399 |
126 | PRKD3 | 0.57992545 |
127 | MAP2K1 | 0.57219632 |
128 | LYN | 0.56371263 |
129 | ITK | 0.56314300 |
130 | PRKCH | 0.55118516 |
131 | CSNK1G2 | 0.52752521 |
132 | FGFR2 | 0.52519557 |
133 | TESK2 | 0.51768599 |
134 | RPS6KA2 | 0.51723383 |
135 | MAP3K11 | 0.51718851 |
136 | FGFR3 | 0.51140195 |
137 | MAPK11 | 0.50107741 |
138 | PRKAA2 | 0.49965712 |
139 | BMX | 0.49626607 |
140 | MUSK | 0.49223744 |
141 | DAPK3 | 0.48524092 |
142 | RPS6KA6 | 0.47683604 |
143 | TAOK2 | 0.46975893 |
144 | ILK | 0.46503106 |
145 | STK11 | 0.46460939 |
146 | WNK1 | 0.43701085 |
147 | PRKACG | 0.43104874 |
148 | MAPK12 | 0.42835329 |
149 | PRKAA1 | 0.42111280 |
150 | PDK1 | 0.41979833 |
151 | PTK2B | 0.41943590 |
152 | EPHB1 | 0.41268082 |
153 | ERBB2 | 0.41163055 |
154 | LCK | 0.40938656 |
155 | CHUK | 0.40170297 |
156 | CDK12 | 0.40108811 |
157 | SIK3 | 0.39714080 |
158 | PRKD1 | 0.38025328 |
159 | NLK | 0.37164666 |
160 | STK10 | 0.36005531 |
161 | TRPM7 | 0.35741266 |
162 | RPS6KA5 | 0.34756501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.73859719 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44073855 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92808238 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.69394992 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61026933 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59147262 |
7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.41891021 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30160933 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.23855205 |
10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.18455739 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17444090 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12679119 |
13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.12441411 |
14 | Bile secretion_Homo sapiens_hsa04976 | 2.08607082 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08341693 |
16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98400113 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94553988 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87561122 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85232269 |
20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.80655937 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76495135 |
22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74356737 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.73080229 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71781376 |
25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70153249 |
26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69972346 |
27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69476556 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65878759 |
29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65062748 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63166462 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61736738 |
32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58664442 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57504261 |
34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56772727 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48854614 |
36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45392698 |
37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43739215 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42669044 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40604019 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38347963 |
41 | Allograft rejection_Homo sapiens_hsa05330 | 1.34072338 |
42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32481853 |
43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26488841 |
44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25829172 |
45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24230560 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.23853643 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20597526 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20306011 |
49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.19530585 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18477365 |
51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12407727 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09331777 |
53 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04470533 |
54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04149125 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02003490 |
56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01664209 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01143530 |
58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96836753 |
59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96404171 |
60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95854414 |
61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95722173 |
62 | Taste transduction_Homo sapiens_hsa04742 | 0.92195041 |
63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91932079 |
64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91857270 |
65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87848288 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84619847 |
67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83976049 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.81132686 |
69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78745484 |
70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78685307 |
71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78150489 |
72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76646946 |
73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76138144 |
74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75707573 |
75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75576520 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74422636 |
77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73964496 |
78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73354903 |
79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73056871 |
80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72392066 |
81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71414258 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70178730 |
83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69157347 |
84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67584791 |
85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65034960 |
86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64561343 |
87 | Salivary secretion_Homo sapiens_hsa04970 | 0.64246972 |
88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63483494 |
89 | Insulin secretion_Homo sapiens_hsa04911 | 0.63016371 |
90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62552654 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61688216 |
92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61200013 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61089829 |
94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59754490 |
95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55413412 |
96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55008487 |
97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54631124 |
98 | Morphine addiction_Homo sapiens_hsa05032 | 0.54506321 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53745287 |
100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52118885 |
101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51243594 |
102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51057795 |
103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49290154 |
104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48940456 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47942592 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47669575 |
107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47585255 |
108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46850796 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46145168 |
110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45095710 |
111 | Lysine degradation_Homo sapiens_hsa00310 | 0.44590533 |
112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43085776 |
113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42154922 |
114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41396147 |
115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41020859 |
116 | Pertussis_Homo sapiens_hsa05133 | 0.40922719 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40667414 |
118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40432942 |
119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35693984 |
120 | Tuberculosis_Homo sapiens_hsa05152 | 0.35109435 |
121 | Mineral absorption_Homo sapiens_hsa04978 | 0.35014077 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34904105 |
123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34123204 |
124 | Lysosome_Homo sapiens_hsa04142 | 0.33373394 |
125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33193002 |
126 | Endocytosis_Homo sapiens_hsa04144 | 0.32621630 |
127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31290644 |
128 | Asthma_Homo sapiens_hsa05310 | 0.30712743 |
129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30348687 |
130 | Influenza A_Homo sapiens_hsa05164 | 0.30315615 |
131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29663250 |
132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29271465 |
133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29123617 |
134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28978806 |
135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28920236 |
136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28726528 |
137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28075242 |
138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26903079 |
139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25775086 |
140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25725226 |
141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23997917 |
142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23279363 |
143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21152279 |
144 | Prion diseases_Homo sapiens_hsa05020 | 0.19117932 |
145 | Long-term depression_Homo sapiens_hsa04730 | 0.17561273 |
146 | Insulin resistance_Homo sapiens_hsa04931 | 0.16485583 |
147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16350729 |
148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16287901 |
149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.15991304 |
150 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.15356907 |